Difficulty: Medium
Average Score: 81%
Practice
Which of the following drugs does not pass blood brain barrier:
Correct answer
D
Rationale
In this question, the correct answer is D) Guanethidine. Guanethidine is the drug that does not pass the blood-brain barrier. The blood-brain barrier is a protective barrier that prevents certain substances from freely diffusing from the bloodstream into the brain tissue. Guanethidine is a large, hydrophilic molecule that cannot easily cross this barrier.
A) Ephedrine is a sympathomimetic amine that can cross the blood-brain barrier due to its small size and structure.
B) Propranolol is a beta-blocker that can also cross the blood-brain barrier because of its lipophilic nature and ability to penetrate the central nervous system.
C) Clonidine is a centrally acting alpha-2 adrenergic agonist that can pass through the blood-brain barrier to exert its effects on the central nervous system.
Educationally, understanding which drugs can or cannot cross the blood-brain barrier is crucial in pharmacology. Drugs that can cross the barrier may have central nervous system effects, while those that cannot are more likely to act peripherally. This knowledge is essential for healthcare professionals to predict a drug's potential side effects or therapeutic benefits.
A) Ephedrine is a sympathomimetic amine that can cross the blood-brain barrier due to its small size and structure.
B) Propranolol is a beta-blocker that can also cross the blood-brain barrier because of its lipophilic nature and ability to penetrate the central nervous system.
C) Clonidine is a centrally acting alpha-2 adrenergic agonist that can pass through the blood-brain barrier to exert its effects on the central nervous system.
Educationally, understanding which drugs can or cannot cross the blood-brain barrier is crucial in pharmacology. Drugs that can cross the barrier may have central nervous system effects, while those that cannot are more likely to act peripherally. This knowledge is essential for healthcare professionals to predict a drug's potential side effects or therapeutic benefits.